116 related articles for article (PubMed ID: 9934582)
21. Angiogenesis and some prognostic parameters of invasive ductal breast carcinoma in women.
Olewniczak S; Chosia M; Kwas A; Kram A; Domagała W
Pol J Pathol; 2002; 53(4):183-8. PubMed ID: 12597334
[TBL] [Abstract][Full Text] [Related]
22. Association of tumour necrosis factor alpha and its receptors with thymidine phosphorylase expression in invasive breast carcinoma.
Leek RD; Landers R; Fox SB; Ng F; Harris AL; Lewis CE
Br J Cancer; 1998 Jun; 77(12):2246-51. PubMed ID: 9649140
[TBL] [Abstract][Full Text] [Related]
23. Examining the technique of angiogenesis assessment in invasive breast cancer.
Martin L; Green B; Renshaw C; Lowe D; Rudland P; Leinster SJ; Winstanley J
Br J Cancer; 1997; 76(8):1046-54. PubMed ID: 9376265
[TBL] [Abstract][Full Text] [Related]
24. Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast.
Brown LF; Guidi AJ; Schnitt SJ; Van De Water L; Iruela-Arispe ML; Yeo TK; Tognazzi K; Dvorak HF
Clin Cancer Res; 1999 May; 5(5):1041-56. PubMed ID: 10353737
[TBL] [Abstract][Full Text] [Related]
25. Immunohistochemical expression of hormone receptors in invasive breast carcinoma: correlation of results of H-score with pathological parameters.
Thike AA; Chng MJ; Fook-Chong S; Tan PH
Pathology; 2001 Feb; 33(1):21-5. PubMed ID: 11280603
[TBL] [Abstract][Full Text] [Related]
26. Angiogenesis in invasive breast carcinoma: is it associated with parameters of prognostic significance?
Miliaras D; Kamas A; Kalekou H
Histopathology; 1995 Feb; 26(2):165-9. PubMed ID: 7537717
[TBL] [Abstract][Full Text] [Related]
27. Expression of sialyl lewis X, sialyl Lewis A, E-cadherin and cathepsin-D in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastasis.
Jeschke U; Mylonas I; Shabani N; Kunert-Keil C; Schindlbeck C; Gerber B; Friese K
Anticancer Res; 2005; 25(3A):1615-22. PubMed ID: 16033070
[TBL] [Abstract][Full Text] [Related]
28. Morphometric and immunohistochemical study of angiogenic marker expressions in invasive ductal carcinoma of human breast.
Safwat MD; Habib F; Elayat A; Oweiss N; Reffat S; Algaidi S
Folia Morphol (Warsz); 2009 Aug; 68(3):144-55. PubMed ID: 19722158
[TBL] [Abstract][Full Text] [Related]
29. Platelet-derived endothelial cell growth factor/thymidine phosphorylase expression in macrophages correlates with tumor angiogenesis and prognosis in invasive breast cancer.
Nagaoka H; Iino Y; Takei H; Morishita Y
Int J Oncol; 1998 Sep; 13(3):449-54. PubMed ID: 9683777
[TBL] [Abstract][Full Text] [Related]
30. Cathepsin-D expression in breast lesion: an immunohistochemical study.
Brujan I; Mărgăritescu C; Simionescu C; Pirici D; Fronie A; Foarfă C; Stepan A; Vrabete M
Rom J Morphol Embryol; 2009; 50(1):31-9. PubMed ID: 19221643
[TBL] [Abstract][Full Text] [Related]
31. Correlated expression of BCL-2 protein, estrogen receptor, cathepsin D and low growth fraction (PCNA) in intracystic papillary breast carcinoma.
Lanzafame S; Emmanuele C; Torrisi A; Magro G
Pathol Res Pract; 1998; 194(8):541-7. PubMed ID: 9779488
[TBL] [Abstract][Full Text] [Related]
32. Microvessel quantitation and prognosis in invasive breast carcinoma.
Bosari S; Lee AK; DeLellis RA; Wiley BD; Heatley GJ; Silverman ML
Hum Pathol; 1992 Jul; 23(7):755-61. PubMed ID: 1377162
[TBL] [Abstract][Full Text] [Related]
33. Inducible nitric oxide synthase expression, apoptosis, and angiogenesis in in situ and invasive breast carcinomas.
Vakkala M; Kahlos K; Lakari E; Pääkkö P; Kinnula V; Soini Y
Clin Cancer Res; 2000 Jun; 6(6):2408-16. PubMed ID: 10873093
[TBL] [Abstract][Full Text] [Related]
34. Long term outcome of small size invasive breast carcinomas independent from angiogenesis in a series of 685 cases.
Vincent-Salomon A; Carton M; Zafrani B; Fréneaux P; Nicolas A; Massemin B; Fourquet A; Clough K; Pouillart P; Sastre-Garau X
Cancer; 2001 Jul; 92(2):249-56. PubMed ID: 11466676
[TBL] [Abstract][Full Text] [Related]
35. Immunohistochemical expression of extracellular matrix components tenascin, fibronectin, collagen type IV and laminin in breast cancer: their prognostic value and role in tumour invasion and progression.
Ioachim E; Charchanti A; Briasoulis E; Karavasilis V; Tsanou H; Arvanitis DL; Agnantis NJ; Pavlidis N
Eur J Cancer; 2002 Dec; 38(18):2362-70. PubMed ID: 12460779
[TBL] [Abstract][Full Text] [Related]
36. Thymidine phosphorylase expression and stromal vascularity in ductal carcinoma in situ of the breast.
Teo NB; Shoker BS; Jarvis C; Sloane JP; Holcombe C
J Clin Pathol; 2003 Dec; 56(12):919-23. PubMed ID: 14645350
[TBL] [Abstract][Full Text] [Related]
37. Microvessel quantitation in breast ductal invasive carcinoma. Correlation with proliferative activity, hormonal receptors and lymph node metastases.
Aranda FI; Laforga JB
Pathol Res Pract; 1996 Feb; 192(2):124-9. PubMed ID: 8692712
[TBL] [Abstract][Full Text] [Related]
38. Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer.
Horak ER; Leek R; Klenk N; LeJeune S; Smith K; Stuart N; Greenall M; Stepniewska K; Harris AL
Lancet; 1992 Nov; 340(8828):1120-4. PubMed ID: 1279332
[TBL] [Abstract][Full Text] [Related]
39. Relation of CD117 immunoreactivity and microvascular density in invasive breast carcinoma.
Amin MM; El-Hawary AK; Farouk O
Indian J Pathol Microbiol; 2012; 55(4):456-60. PubMed ID: 23455779
[TBL] [Abstract][Full Text] [Related]
40. Expression of cell adhesion molecules, CD44s and E-cadherin, and microvessel density in invasive micropapillary carcinoma of the breast.
Gong Y; Sun X; Huo L; Wiley EL; Rao MS
Histopathology; 2005 Jan; 46(1):24-30. PubMed ID: 15656882
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
